ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko00592	alpha-Linolenic acid metabolism	4/112	19/7206	0.000179029587043
ko04146	Peroxisome	7/112	89/7206	0.000438051799631
ko00564	Glycerophospholipid metabolism	7/112	99/7206	0.000833374150694
ko00590	Arachidonic acid metabolism	5/112	52/7206	0.00120474617354
ko04610	Complement and coagulation cascades	6/112	79/7206	0.00136356071155
ko05321	Inflammatory bowel disease (IBD)	5/112	56/7206	0.00168567932032
ko05150	Staphylococcus aureus infection	4/112	36/7206	0.00222039226722
ko05152	Tuberculosis	9/112	187/7206	0.00242516063464
ko05323	Rheumatoid arthritis	6/112	89/7206	0.00251508142578
ko03320	PPAR signaling pathway	5/112	69/7206	0.00422855063537
ko04630	Jak-STAT signaling pathway	7/112	132/7206	0.00434106463716
ko05144	Malaria	4/112	45/7206	0.00504650853534
ko00950	Isoquinoline alkaloid biosynthesis	2/112	10/7206	0.00993173981161
ko05340	Primary immunodeficiency	3/112	30/7206	0.0109368865422
ko04611	Platelet activation	7/112	163/7206	0.0132618512091
ko00561	Glycerolipid metabolism	4/112	63/7206	0.0163116027823
ko04672	Intestinal immune network for IgA production	3/112	37/7206	0.0193557377165
ko04960	Aldosterone-regulated sodium reabsorption	3/112	41/7206	0.025398581567
ko00360	Phenylalanine metabolism	2/112	17/7206	0.0279678387265
ko05140	Leishmaniasis	4/112	75/7206	0.0289162237238
ko00071	Fatty acid degradation	3/112	45/7206	0.0323412951118
ko04072	Phospholipase D signaling pathway	7/112	197/7206	0.0333716083177
ko05212	Pancreatic cancer	4/112	83/7206	0.0398242193468
ko00591	Linoleic acid metabolism	2/112	22/7206	0.0451827379145
ko05145	Toxoplasmosis	5/112	126/7206	0.0460527872988
ko05166	HTLV-I infection	9/112	292/7206	0.0468250289406